Theresa A. Koomson

Theresa A. Koomson serves as a Contracting Officer responsible for managing complex acquisitions in scientific and technical research domains. She plays a pivotal role in advancing mission-critical R&D initiatives by executing full and open competitions under FAR Part 15 procedures, ensuring compliance with federal acquisition regulations and performance-based contracting standards. Her portfolio centers on securing innovative solutions in physical, engineering, and life sciences, with a focus on outcomes-driven contract vehicles such as Indefinite-Delivery, Indefinite-Quantity (IDIQ) and Other Transaction Authority (OTA) agreements where applicable. Koomson ensures rigorous source selection processes, emphasizing technical merit, past performance, and cost realism to deliver high-value scientific capabilities. Koomson’s contractor relationships are broad-based and competitive, engaging a diverse pool of prime contractors with proven expertise in laboratory services, data analytics, engineering modeling, and experimental research. She consistently fosters transparent, fair, and competitive environments, working with both large institutional research firms and specialized technical service providers. Her procurement approach prioritizes technical capability over size, encouraging innovation through open market engagement and robust solicitation development. Koomson’s contracting patterns reflect a strong preference for full and open competition, with 100% of her acquisitions classified as “No Set-Aside.” This reflects a strategic focus on maximizing competition and technical excellence rather than socioeconomic set-asides. While she does not prioritize 8(a), HUBZone, or SDVOSB set-asides, her processes remain fully compliant with small business goals, and small businesses are welcome to compete on equal footing in open solicitations. Her primary procurement focus is on NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). She routinely procures services including laboratory testing, computational modeling, materials characterization, clinical trial support, and engineering prototyping. Koomson’s expertise lies in managing technically complex, high-stakes R&D contracts requiring specialized scientific oversight and rigorous performance metrics.